| 3D | 3 dimensional |
| BBB | Blood-Brain Barrier |
| CCI | Controlled Cortical Impact |
| CDC | Centers for Disease Control and Prevention |
| CM-hMSCA | culture medium from human adipose-derived mesenchymal stem cells |
| CNS | central nervous system |
| CS-HEC-HA/GP | chitosan, hydroxyethyl cellulose, hyaluronic acid, and b-glycerophosphate (hydrogel) |
| DCX | Doublecortin |
| DAMPS | Damage-associated Molecular Pattern Molecules |
| DPI | Days Post Injury |
| EPM | elevated plus maze |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| HB-adMSC | human adipose-derived mesenchymal stem cell |
| hMgSCs | human meningioma stem-like cells |
| hUC-MSC | human umbilical cord mesenchymal stem cells |
| ICMS | intracortical microstimulation |
| IL-1β | Interleukin-1 Beta |
| IL-4 | Interleukin-4 |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| LPS | lipopolysaccharide |
| MSC | Mesenchymal Stem Cell |
| mNSS | modified neurological severity score |
| MP | methylprednisolone |
| NDD | Neurodegenerative Disorder |
| OF | open field |
| R-GSIK | RADA4GGSIKVAV |
| SE | status epilepticus |
| TBI | Traumatic Brain Injury |
| TNF-α | Tumor Necrosis Factor-Alpha |